Skip to news
JQJO
Latest

FDA announces prazosin recall over nitrosamine concerns | JQJO

FDA announces prazosin recall over nitrosamine concerns

FDA announces prazosin recall over nitrosamine concerns

Tap title to read story

0:00 / 0:38

The U.S. Food and Drug Administration says more than 580,000 bottles of prazosin hydrochloride have been voluntarily recalled nationwide over possible nitrosamine impurities considered potentially cancer causing. New Jersey-based Teva Pharmaceuticals USA and distributor Amerisource Health Services initiated the recall of multiple capsule strengths earlier this month. The FDA assigned the affected lots a Class II risk, noting that prazosin relaxes blood vessels to lower blood pressure and is sometimes used for PTSD-related nightmares and sleep disturbances.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Putin Criticizes EU at APEC Summit

Tap title to read story

0:00 / 0:44

MLB Lockout Threatens 2027 Season

Tap title to read story

0:00 / 0:35

Bedard Injured, Blackhawks Win 6-3

Tap title to read story

0:00 / 0:37

PS5 Update Needed for GTA 6

Tap title to read story

0:00 / 0:41

JQJO

Find your next story

Search JQJO’s current coverage.